Ciphergen Patent Licensing Spat Sent To Arbitration

Law360, New York (July 12, 2010, 3:57 PM EDT) -- A California appeals court has ordered Molecular Analytical Systems Inc. to arbitrate its contract and fraud claims against Ciphergen Biosystems Inc. and Bio-Rad Laboratories Inc. pursuant to a licensing and settlement agreement in an earlier patent infringement dispute over laser technology.

A three-judge panel in the Sixth Appellate District of the California Court of Appeal on Friday reversed a lower court's denial of a bid by Ciphergen and Bio-Rad to compel arbitration, ruling that Molecular's claims alleging breach of a settlement agreement between it and Ciphergen...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.